Instructions for use Save this presentation Feel free to add or - - PowerPoint PPT Presentation

instructions for use
SMART_READER_LITE
LIVE PREVIEW

Instructions for use Save this presentation Feel free to add or - - PowerPoint PPT Presentation

Instructions for use Save this presentation Feel free to add or delete slides as necessary, change information to suit local needs and as new guidance or evidence is published Disclaimer: Whilst the working group has made every effort to


slide-1
SLIDE 1

 Save this presentation  Feel free to add or delete slides as necessary, change information to suit local needs and as new guidance or evidence is published

Disclaimer: Whilst the working group has made every effort to ensure the accuracy of information provided the ICNA and 3M cannot be responsible for any alterations made by users to the presentation to meet local needs.

Instructions for use

slide-2
SLIDE 2
slide-3
SLIDE 3

 Understand the impact and causes of infection associated with vascular access  Identify signs and symptoms of infection in vascular access  Explain procedures involved with safe insertion, maintenance and removal of intravascular devices to reduce the risks of infection

Objectives

slide-4
SLIDE 4

 9% of hospital inpatients at any one time will acquire an infection during their stay1  There are at least 100,000 HAI a year1  5,000 deaths a year2  Financial impact

  • 1. Auditor General (2000) the management and control of Hospital Acquired Infection in Acute NHS in England.
  • 2. DOH CMO (England) (2002) Getting ahead of the curve

The Impact of Healthcare Associated Infection (HCAI)

slide-5
SLIDE 5

 National Audit Office

– Suggests that 10-15% of HCAI can be prevented – Good application of Infection Control policies and principles

National Audit Office 2000

Preventing HCAI

slide-6
SLIDE 6

 Incidence of blood stream infections

– 0-15% (Elliott 1993) – Central catheters responsible for 31% hospital bacteraemias, peripheral lines 7% (PHLS 2000) – Paediatrics: 3-11 / 1000 catheter days (Seguin et al. 1994)

The extent of the problem

slide-7
SLIDE 7

 Up to 80% of hospitalised patients will receive some form

  • f I.V. therapy (Wilkinson 1996)

 Nystrom et al. (1983) studied 10,616 surgical patients.

– 63% had an I.V. device – 10.34% thrombophlebitis

The extent of the problem (2)

slide-8
SLIDE 8

General Principles of Infection Control

 Remove the source of infection  Block routes of spread  Enhance the patient’s resistance to infection

slide-9
SLIDE 9

 Patient Factors  External Factors

Risk Factors for Infections

slide-10
SLIDE 10

 Local infection

– Local inflammation – Discharge around line – Erythema – Pain/discomfort

 Systemic infection

– Fever – Rigors when line is in use – Tachycardia – Metastatic infection

Vascular Access Associated Infections

slide-11
SLIDE 11

 Coagulase – Negative Staphylococci (CNS) 30-40%  Staphylococcus aureus 5-10%.  Enterococcus 4-6%.  Pseudomonas aeruginosa 2-6%.  Candida 2-5%; Enterbacter 1-4%; Acinetobacter 1-2%; Serratia <1%

Centres for disease Control and Prevention (2002) Guidelines for the Prevention of Intravascular catheter – related Infections. Morbidity and Mortality weekly report. Vol. 51/ No. RR-10.

Common pathogens in bacteraemia

slide-12
SLIDE 12

 Endogenous

– Infection arising from patient’s own organisms

 Exogenous

– Infection originating from organism outside of the patient’s body including environment, equipment & staff hands

Routes of Infection

slide-13
SLIDE 13

 Intrinsic contamination occurs prior to the use of the equipment

– manufacturing problem, poor storage

 Extrinsic contamination occurs at any point during the insertion, use or removal of the device

– Poor hand hygiene, poor aseptic technique

Sources of Exogenous Infection

slide-14
SLIDE 14

 Extraluminal

– Organisms access the vein via outside of catheter

 Intraluminal

– Organisms access the vein via lumen of catheter

 Haematogenous

– Organisms from other sites transferred by blood flow to catheter

Extraluminal, intraluminal & haematogenous routes

slide-15
SLIDE 15

HAEMATOGENOUS SEEDING SKIN COLONISATION

slide-16
SLIDE 16

 epic National Evidence Guidelines for Infection Control  NICE Infection Control prevention of HCAI in primary and community care  ICNA Guidelines for Preventing Intravascular Catheter- Related Infections

Guidelines

slide-17
SLIDE 17

Other national resources

 Winning Ways  Savings Lives

slide-18
SLIDE 18

 Provide service in best interest to patient / client

– Policies based on national standards and guidelines

 Necessary skills and competence  Provide care in partnership

– Patient / carer information

 Evaluate

– Practice, clinical outcomes

 Report

– Adverse outcomes, limitations

Professional Issues

slide-19
SLIDE 19

 Assessment of need  Line choice  Insertion site choice  Insertion technique  Site care  Line management  Asepsis  Hand hygiene

Principles of PIVA

slide-20
SLIDE 20

 Does the patient need I.V. access

– Alternative administration of therapy

 What treatment is to be administered

– Influence catheter type

Assessment of need

slide-21
SLIDE 21

 Peripheral line (PVC)

 Ported vs. unported

 Peripherally Inserted Central Catheter (PICC)  Other alternative e.g. vascuports  Paediatric: Umbilical catheters

Line choice

slide-22
SLIDE 22

 Central line (CVC)

 Single lumen unless multiple ports essential  Use tunnelled catheter or implantable port for long term devices

(more than 30 days)

 Consider antimicrobial impregnated CVC for high risk adult

patients who require short-term treatment (less than 10 days)

Line choice (2)

slide-23
SLIDE 23

 Assess risks for infection against risk of mechanical complications  Use subclavian line as a preference unless medically contraindicated  Consider using PICC as alternative to subclavian or jugular access  PVC – site choice where least mechanical irritation

Insertion site choice (adult)

slide-24
SLIDE 24

 Assess risks for infection against risk of mechanical complications  Most CVCs will be jugular or femoral (subclavian

  • ccasionally)

 Consider using PICC as alternative to subclavian or jugular access  PVC – site choice where least mechanical irritation

Insertion site choice (paediatric)

slide-25
SLIDE 25

 Aseptic technique  Standard precautions utilised  70% Isopropyl Alcohol skin preparation

Insertion technique – PVC

slide-26
SLIDE 26

 Full aseptic technique  Full body drape with access to insertion site only  Full surgical attire by operator and assistant (epic 2001)  Alcoholic chlorhexidine skin preparation (alcoholic poviodine-iodine solution for patients with history

  • f chlorhexidine sensitivity)

Allow the antiseptic to dry before inserting catheter

Insertion technique – CVC

slide-27
SLIDE 27

 Intact sterile, transparent, semi-permeable polyurethane dressing  CVC dressing changed every 7 days or sooner if it becomes wet, loose or soiled  Before accessing the system disinfect external surfaces of the catheter hub and connection ports with alcoholic chlorhexidine gluconate or povidone-iodine unless contraindicated by manufacturer

Site care

slide-28
SLIDE 28

 Insertion sites should be checked at least daily for signs of inflammation and document using VIP score

Site care (2)

slide-29
SLIDE 29

 Lines should be handled as little as possible  Injection ports should be disinfected with alcohol wipes  Replace all tubing when vascular device is changed  Change tubing, stopcocks etc no more frequently than every 72-96 hours (unless clinically indicated)  Replace tubing from blood transfusion within 24 hours of initiation and on completion  Replace tubing following infusion of lipids within 24 hours of initiation

Line management

slide-30
SLIDE 30

 Asepsis is defined as the method by which microbial contamination is prevented during invasive procedures or

  • f breaches in the skin’s integrity

 Aseptic techniques are methods that have been developed to ensure that only uncontaminated objects / fluids make contact with sterile / susceptible sites

Asepsis

Full compliance with aseptic technique is essential for handling any line

slide-31
SLIDE 31

 Compliance with aseptic technique must be used to insert all central lines  Skin should be disinfected before inserting any catheter

– Alcoholic chlorhexidine gluconate (alcoholic povidone-iodine in sensitivity) for CVC and PICC – Alcohol wipe for PVC – Allow preparation to dry before insertion

 Use sterile gloves for CVC manipulation (based on risk assessment)  Hands must be decontaminated prior to any line manipulation / intervention

Aseptic technique

slide-32
SLIDE 32

 Hand hygiene is the principle factor to reduce risks of introducing micro-organisms  Hands must be washed / decontaminated before and after any manipulation / intervention associated with the line

– Administering drugs, changing infusions, inserting lines, changing dressings

 Hands must be washed after removing gloves

Hand hygiene

slide-33
SLIDE 33

 Soap and water

 Wet hands  Wash using Ayliffe 6 step technique  Rinse  Dry thoroughly

– To remove physical dirt / organic matter

 Alcohol based hand rubs

– Physically clean hands – In absence of appropriate hand washing facilities

 Hand care

Hand hygiene (2)

slide-34
SLIDE 34

Hand hygiene (3)

slide-35
SLIDE 35

 Patients / carers should be trained how to look after a long term line

– Reducing risks of infection – Identifying signs and symptoms of infection – How to report concerns

Patient information

slide-36
SLIDE 36

 Surveillance

– Site infection surveillance (incidence, rates) – Bloodstream infection associated with vascular devices

 Mandatory bacteraemia reporting

– Root-cause analysis

Infection prevented?

slide-37
SLIDE 37

 Audit

– Practices, local and organisational

 Insertion, management, documentation

 Department of Health, ICNA audit tool  Saving Lives

– High impact intervention No. 1 & 2

 PIVA audit tools

Infection prevented? (2)

slide-38
SLIDE 38

Infection prevention and control is everybody’s responsibility every day!

slide-39
SLIDE 39

Any Questions? Thank you for listening!